Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer

NCT03151447 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

RADIATION: stereotactic body radiation therapy

Sponsor

Fudan University